Gooch & Housego (GHH) AGM 2026 presentation summary
Event summary combining transcript, slides, and related documents.
AGM 2026 presentation summary
11 Mar, 2026Financial and operational highlights
Full year revenue increased by 10.7% to £150.5m, with adjusted profit before tax up 46.8% to £11.9m.
Aerospace & Defence revenues surged 52.1%, while Industrial declined 5.3% and Life Sciences remained stable.
Closing order book rose 36.2% to £142.3m, with strong pipeline growth, especially in Aerospace & Defence.
Net bank debt increased to £29.9m due to acquisitions and inventory investment.
Operational performance improved despite supply chain and macroeconomic challenges.
Strategic direction and technology focus
Strategy centers on innovation, customer focus, and sustainable growth through high-performance teams and technology investment.
R&D spend was £7.3m, with a 25% increase in new product revenues to £31.7m.
Technology roadmap narrowed to six key areas for differentiation and value creation.
Over £50m in margin-accretive business expected from new products in the medium term.
Acquisitions and integration
Acquisitions of Phoenix Optical and Global Photonics are accelerating transformation and expanding capabilities.
Phoenix Optical delivered over 100% order book growth and enhanced Germanium fabrication.
Global Photonics added US manufacturing capacity and expertise in defence optics.
Latest events from Gooch & Housego
- Revenue up, profit down; strong order book and A&D/Life Sciences offset industrial weakness.GHH
H2 202411 Mar 2026 - Revenue and profit fell, but improved margins and a strong order book support a positive outlook.GHH
H1 202411 Mar 2026 - Acquisition creates a U.S. optical systems hub, boosting defense capabilities and growth potential.GHH
M&A announcement11 Mar 2026 - Revenue and profit surged, led by A&D and Life Sciences, with strong order cover for FY2025.GHH
H1 202511 Mar 2026 - Double-digit revenue and profit growth driven by A&D and acquisitions, with a record order book.GHH
H2 202511 Mar 2026 - Solid FY2024 results and acquisitions set the stage for growth in Life Sciences and Defence.GHH
Investor presentation11 Mar 2026 - Order book grew to £126.4M, driven by innovation, acquisitions, and operational improvements.GHH
AGM 2025 presentation11 Mar 2026 - Revenue delays impact FY2024, but strategic progress and FY2025 outlook remain strong.GHH
Trading update11 Mar 2026 - Strong second half trading and robust cash generation position the group for next year's recovery.GHH
Trading update11 Mar 2026